[Review of current issues of diagnosis and prevention of blood-borne nosocomial viral infections]
- PMID: 32168439
- DOI: 10.36233/0507-4088-2019-64-6-262-267
[Review of current issues of diagnosis and prevention of blood-borne nosocomial viral infections]
Abstract
Provision of infection security in transplantology and transfusiology is a challenging and significant problem that depends on the quality of medical donor selection and laboratory diagnosis of the blood collected. At present, a large number of blood-borne viruses are known; nevertheless, in Russia, the list of viral agents to be tested during the examination by the blood service boils down to three ones: HIV, hepatitis C and hepatitis B viruses. The review article demonstrates the need for implementation of additional laboratory tests for the agents of the priority healthcare-associated blood-borne infections (HAI) using a risk-based approach, i.e., on specified sites and in high risk groups. It presents a methodology for determination of a quantitative blood-induced infection residual risk (BIRR) index to be used while evaluating the efficiency of viral security provision in the blood service.
Keywords: blood-borne nosocomial viral infections; hemotransfusion; residual risk of a blood-induced infection.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Towards the prevention of transfusion-transmitted infectious diseases.Expert Rev Anti Infect Ther. 2003 Aug;1(2):267-74. doi: 10.1586/14787210.1.2.267. Expert Rev Anti Infect Ther. 2003. PMID: 15482122 Review.
-
Human retroviruses: a decade of discovery and link with human disease.J Infect Dis. 1991 Aug;164(2):235-43. doi: 10.1093/infdis/164.2.235. J Infect Dis. 1991. PMID: 1677372 Review. No abstract available.
-
Transfusion-transmitted infections among multitransfused patients in Iran: a review.Transfus Med. 2007 Dec;17(6):425-33. doi: 10.1111/j.1365-3148.2007.00794.x. Transfus Med. 2007. PMID: 18067646 Review.
-
The spectrum of safety: a review of the safety of current hemophilia products.Semin Hematol. 2003 Jul;40(3 Suppl 3):10-5. doi: 10.1016/s0037-1963(03)80740-0. Semin Hematol. 2003. PMID: 14690063 Review.
-
[Controlled viral risks].Transfus Clin Biol. 2000 Feb;7(1):24-9. doi: 10.1016/s1246-7820(00)88708-x. Transfus Clin Biol. 2000. PMID: 10730343 Review. French.
Publication types
MeSH terms
LinkOut - more resources
Medical